New York, September 28, 2026 / PRNewswire / -- Lazard, Inc. (New York Stock Exchange ticker: LAZ) Today, it was announced that Pranjal Gambhir has joined the company as the head of the medical technology business, based in New York.

In this position, Pranjal will be responsible for leading the company's coverage of medical technology enterprises and providing advice to clients on strategies and business development transactions within this industry.

Lazard, the Global Head of Healthcare Business, David Gluckman stated: " Pranjal has extensive and profound experience in the field of medical technology. His joining has enhanced our coverage capabilities that we can offer to customers. His background across multiple sub-sectors also adds more strategic depth to our healthcare team, helping us continue to expand our business."

Pranjal previously worked at Citigroup, most recently serving as Managing Director, responsible for overseeing medical technology companies across various niche sectors. He has been with Citigroup for 20 years and has held several positions in New York and New Delhi.

Pranjal Gambhir indicates that the medical technology industry is still evolving rapidly, which brings both opportunities and complexities to customers. The independent perspective and global platform of Lazard are exactly what the management team, board of directors, and investors need, and I look forward to helping them tackle future challenges.

Pranjal holds a Master of Business Administration degree from the Indian School of Business, as well as a Bachelor of Commerce degree from the University of Delhi.

Lazard was established in 1848 and is a financial advisory and asset management company with operations spanning North America, South America, Europe, the Middle East, Asia, and Australia. Lazard provides advisory services in mergers and acquisitions, capital markets and capital solutions, restructuring and debt management, geopolitics, and other strategic matters. It also offers asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high-net-worth individuals. Lazard is listed on the New York Stock Exchange under the names Lazard and Inc, with the stock code being LAZ.